Leveraging our Rich Heritage to Develop an Exceptional Line of

Leveraging our Rich Heritage to Develop an Exceptional Line of

Jay Pharma is developing a differentiated line of over-the-counter (OTC) products to improve the lives of persons suffering from cancer. Cancer and its treatment often cause side effects – we believe that improving quality of life and supporting patients and their families is a critical part of cancer care. Jay Pharma will take an evidence-based approach to developing its line of OTC products, and is initially focused on providing symptomatic relief of pain, anxiety, sleep difficulties, and lack of appetite.

Jay Pharma plans to leverage proprietary products developed by our partner Tikun Olam, the leading supplier of medical cannabis in Israel, and one of the leading, research-focused medical cannabis companies globally. Tikun Olam employs evidence-based medicine and other best practices and its products have been studied in numerous medical trials. Tikun Olam patient databases include 12,000+ persons treated across a variety of conditions, with a primary focus on cancer care.

Avidekel

Avidekel is an indica-dominant strain of cannabis that is high in CBD and low in THC.

Learn More

Midnight

Midnight is a sativa-dominant strain of cannabis with a one-to-one ratio of CBD to THC.

Learn More

Erez

Erez is an  indica-dominant strain of cannabis that is high in THC and low in CBD.

Learn More